[Isolated limb perfusion with tumor necrosis factor and melphalan for locally advanced soft tissue sarcoma].
Kettelhack
Ch
Ch
Allgemeinchirurgische Klinik, Universitätsspital Basel.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D005121:Extremities / Q000098:blood supply; D005500:Follow-Up Studies; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects; D012509:Sarcoma / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage* / Q000009:adverse effects
D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan